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Background. Needleless connectors (NC) are used on virtually all intravascular devices, providing an easy access point for infusion
connection. Colonization of NC is considered the cause of 50% of postinsertion catheter-related infections. Breaks in aseptic
technique, from failure to disinfect, result in contamination and subsequent biofilm formation within NC and catheters increasing
the potential for infection of central and peripheral catheters.Methods.This systematic review evaluated 140 studies and 34 abstracts
on NC disinfection practices, the impact of hub contamination on infection, and measures of education and compliance. Results.
The greatest risk for contamination of the catheter after insertion is the NC with 33–45% contaminated, and compliance with
disinfection as low as 10%. The optimal technique or disinfection time has not been identified, although scrubbing with 70%
alcohol for 5–60 seconds is recommended. Studies have reported statistically significant results in infection reduction when passive
alcohol disinfection caps are used (48–86% reduction). Clinical Implications. It is critical for healthcare facilities and clinicians
to take responsibility for compliance with basic principles of asepsis compliance, to involve frontline staff in strategies, to facilitate
education that promotes understanding of the consequences of failure, and to comply with the standard of care for hub disinfection.
1. Background
Intravenous catheters and those related devices used to gain
access to the veins for the purpose of infusing medications
or solutions have evolved significantly over the past three
decades. One of the more noticeable changes involves the
way intravenous devices are accessed. Early concerns over
needle safety for healthcare workers led to the creation
of products that provide needle-free access. While these
products did eliminate the risk of accidental needle injury
for the clinician, some needleless products raised new issues
for the patient; namely, a noted increase in the occurrence
of catheter associated bloodstream infections (CABSI) and
central line associated bloodstream infections (CLABSI) [1–
3]. Risk factors for infection include poor adherence to asep-
tic technique, needleless connector (NC) design variations,
and inconsistent health care staff education and training
[1–3]. NC are used on virtually all intravascular devices
in the USA; they provide an easy access point for syringe
or tubing attachment and have now become the central
access point for all connections. Yet, despite providing some
level of safety, concerns over infection related to NC con-
tamination exist. Surface design, gaps around valve closure
surface, segmented fluid pathway with dead space, differing
internal mechanisms, clear or obscured visibility, variable
blood reflux, clamping sequences, and different flushing
instructions, depending on the type of NC, all play a part
in the level of risk associated with the device. Before the
advent of NC, clinicians had an intuitive understanding that
prior to penetrating the septum with the needle the septum
required disinfection. Current surface disinfection of NC
is not necessarily intuitive. Initially, needleless split septum
access points used a blunt “needle-looking” type cannula.
As a result, the disinfection process remained intuitive. Split
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septum access devices continue to be recommended as a
lower risk option for needleless connection; however, they
have lost popularity because they require multiple parts and
pieces for access and allow direct needle access through the
septum/diaphragm leading many facilities to switch to luer
access devices. With the changes to the access point using
direct luer connection through the NC, the intuitive sense to
disinfect the surface prior to access is lost; many clinicians
fail to realize the consequences of this breech in aseptic
technique [4–6]. Colonization of catheter hubs and NC,
with subsequent bacterial ingress into the catheter lumen, is
considered the cause of 50% of postinsertion catheter-related
infections [3–7]. Disinfection of the exposed surface of the
NC is necessary to avoid contamination and subsequent
intraluminal biofilm formation and protect patients from
infection.
Vast improvements have been made in the reduction of
CLABSIs attributed to insertion procedures.The results of the
groundbreaking Keystone initiative demonstrated the effect
of five measures, known as the Central Line Bundle, on the
improvement of outcomes during insertion of central venous
catheters [64, 105]. Consistent application of the bundle,
with compliance verified during the insertion procedure
(checklist), has reduced insertion related CLABSI by more
than 44% in the USA [52]. However, despite the successes
of the insertion bundle, full compliance more than seven
years later is still lacking, with reported compliance rates at
one institution ranging from 0.0% at the beginning of the
intervention to 37.1% (139/375), according to the Jeong study,
with similar results in other institutions [65, 66, 106, 107].
Even in institutionwhere full compliance of the bundle exists,
CLABSIs are still occurring [108]. Disinfection of the NC
access site was not included in the insertion related central
line bundle. The goal of any effective infection prevention
program is zero CLABSIs. To reach the goal of zero, consid-
eration must be given for the pathogenesis of catheter related
infections and an investigation into current human factors of
catheter management preventing achievement of this goal.
Whilemany experts agree that application of the insertion
bundle is one of the best ways to prevent insertion-related
infection, the bundle does not address NC, aseptic access,
or any postinsertion catheter usage issues. A Pennsylvania
study reported that 71.7% (468/653) of central line infections
occurred five days or more after insertion and may have
been directly related to use and care of intravascular devices
[60, 108–110]. Contamination of the catheter directly through
the catheter hub has been confirmed through published
studies [12, 13, 111–113]. These studies found that bacteria
identified on external hub surfaces were also present in
biofilm sampled from random locations within the needless
connector. Research performed at one institution revealed
that patient skin flora was not the source of catheter related
bloodstream infections in any of their cases; all infections in
this study originated from the catheter hub [6, 113]. Infections
later in the life of the catheter develop from improper catheter
manipulation, failure to perform hand hygiene, inadequate
time to clean NC, inadequate training, and poor access
and exit site management [2, 67, 110, 112]. Disinfection of a
catheter hub prior to flushing or prior to the administration
of medications is required for all aseptic access, yet in the
Karchmer study, 31% of clinicians did not even attempt
to disinfect, even when under active observation [1, 64,
88, 114]. In a study by Lee the disinfection compliance by
clinicians prior to NC access was measured at only 10% [115].
This common break in aseptic technique sets the stage for
biofilm formation within NC and catheters and increases the
potential for delayed infection of both central and peripheral
catheters [14, 60, 68, 112, 116]. The results of the Pennsylvania
Patient Safety Advisory Report and independent biofilm
sampling of NC suggest that more attention is needed for
aseptic access and maintenance practices [109].
2. What Is Disinfection?
According to the Epic3 Evidence-Based Guidelines for Pre-
venting Healthcare Infections, disinfection is defined as the
use of chemical or physical methods to reduce the number
of pathogenic microorganisms on surfaces to a level at
which they are not able to cause harm, but which does
not usually destroy spores [53]. These guidelines further
state that disinfection methods used in combination with
cleaning blood or other debris off the surface as disinfectants
have limited ability to penetrate organic material [8]. The
Association for Professionals in Infection Control (APIC)
defines disinfection as a process to eliminatemicroorganisms
accomplished with the use of liquid chemicals or pasteur-
izing; process works best by having proper contact time
and dilution of disinfection agent [117]. Recommendations
from the Centers for Disease Control [8], the Agency for
Healthcare Research and Quality [9], the Society for Health-
care Epidemiology of America [10], and the Infusion Nurses
Society [11, 118] state that NC should be consistently and
thoroughly disinfected using mechanical friction with 70%
alcohol, alcoholic chlorhexidine, or povidone iodine prior to
each access of an intravascular device and listed in evidence
as a Category 1A.
2.1. Goal. Thegoal of this review is to assess current literature
related to disinfection of NC to establish recommendations
that promote aseptic access, reducing infection risk for the
patient.
2.2. Search Methodology. The purpose of this systematic
review was to evaluate the supporting evidence for disin-
fection practices of NC, catheter hub, stopcock, and side
ports that reduce the transfer of microorganisms through
intravascular device access. This report is based on an
electronic systematic literature search and review of pub-
lished materials from Pubmed, Medline, Scopus, Ovid, jStor,
CINAHL, Cochrane, Athens, and ScienceDirect by cross-
referencing these key terms for years 1977–December 2014.
High level evidence from RCTs that tested “cause and effect”
relationships between different disinfection approaches for
NC and patient infection was initially sought. Since no RCTs
were found, lower level evidence including clinical and in
vitro (laboratory) studies was reviewed, as long as these
included reporting of quantitative data. Broad MeSH search
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term “disinfection” and “needleless connector” combinations
were used with additional keywords listed below:
(i) disinfection, antiseptic, alcohol, chlorhexidine, and
anti-infective agents,
(ii) intravenous, intravascular, and vascular access,
(iii) hub, catheter hub, scrub the hub,
(iv) intravenous connector, NC, luer activated device, and
mechanical valve,
(v) aseptic practices, contamination, and compliance,
(vi) education, staff education, and medical education,
(vii) infection, infection prevention, catheter related infec-
tions, CLABSI, bloodstream infections, bacteremia,
sepsis, and cross-infection,
(viii) catheter maintenance and line care,
(ix) insertion and bundle,
(x) intravenous technology,
(xi) catheter cap, access port, disinfecting cap, antimicro-
bial cap, hub protection cap, and port protector,
(xii) Infection prevention guidelines and recommenda-
tions.
Additional studies were cross-referenced throughmanual
search. Conference posters and abstracts were included in
the review. Manufacturers websites of disinfection ports and
two manufacturers (Excelsior Medical, Neptune, NJ; Ivera
Medical Corporation, SanDiego, CA)were contacted directly
requesting all published materials and posters on disinfec-
tion products. There were no identified formal published
systematic reviews of the effectiveness of NC disinfection
practices, indicating a knowledge gap in this area. Search
results were evaluated by title, abstract, and content. Selected
papers were subjected to full-text assessment. Initial selection
process and critique was performed by one researcher (NM),
with evidence rating performed by two researchers indepen-
dently (NM and JF), with any disagreement in quality rating
resolved by discussion.
2.3. Inclusion/Exclusion Criteria. Criteria checklist for inclu-
sion was any NC disinfection publications and abstracts
that fit subcategories for disinfection, hub contamina-
tion/infection prevention, education/compliance, surveys,
and guidelines/recommendations for disinfection. Inclusion
criteria consisted of publications meeting search terms and
topic requirements under sub groupings:
(1) disinfection agents used on intravascular device sur-
faces including studies and reviews of NC and infec-
tion prevention,
(2) sources of contamination through intravascular
devices,
(3) education and compliance for infection prevention,













(ii) studies of adult, pediatric, or neonatal increasingly
important role patients not inclusive of intravascular
device disinfection practices,
(iii) primary populations outside acute care,
(iv) publications not translated into English,
(v) studies prior to 1984.
3. Results
The systematic review of these topics yielded a total of
433 papers and abstracts. After initial review 259 articles
did not meet eligibility requirements and were removed.
Included studies consisted of 140 publications dealing
with disinfection/catheter hub/NC contamination with 34
abstracts/posters. Of the studies 67 were graded according
to the strength of the study. The study results and ratings of
the literature are included in Tables 1–5 and Figure 1, with
recommendations are represented in Table 6.
3.1. Why Disinfect? A catheter is inserted into a vein or artery
to provide a pathway for the administration of medications
or solutions necessary to improve a patient’s health or
condition. Because catheters provide an open conduit into the
vasculature, a NC is attached, via luer threaded connection,
to the integrated hub end of the catheter establishing a
closed system. Studies reflecting benefits of closed systems
with NC have trended toward demonstration of protection
for catheter and hub colonization [4, 119]. In a prospective
controlled study by Rosenthal and Maki and multicenter
prospective cohort by Rangel-Frausto et al., open systems
compared to closed systems resulted in major reductions in
catheter related infections [120]. NC used as a closed system
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Table 1: Disinfecting agents and devices literature.
Grade∗
(1) J. Bak et al., Photochem Photobio, vol. 87, pp. 1123–1128, 2011. D
(2) J. Bak and T. Begovic, J Hosp Infect, vol. 84, pp. 173–177, 2013. D
(3) J. D. Brown, H. A. Moss, and T. S. Elliott, J Hosp Infection, vol. 36, pp. 181–189, 1997. D
(4) A. L. Buchman, J. Spapperi, and P. Leopold, J Vasc Access, vol. 10, no. 1, pp. 11–21, 2009. D
(5) A. L. Casey et al., J Hosp Inf, vol. 54, no. 4, pp. 288–293, 2003. B
(6) C. Chernecky, L. Casella, E. Jarvis et al., J Research Nsg, vol. 15, no. 5, pp. 405–415, 2010. D
(7) M. DeVries, P. S. Mancos, and M. J. Valentine, J Assoc Vasc Access, vol. 19, no. 2, pp. 87–93, 2014. C
(8) K. Field, C. McFarlane et al., Infect Control Hosp Epidemiol, vol. 28, no. 5, pp. 610–613, 2007. C
(9) P. Gould and A. Oudakker, “Getting to ZERO central line associated bloodstream infections,” Poster AVA,
National Harbour, M.d., USA, September 2010. C
(10) K. Guerin, J. Wagner, K. Rains, and M. Bessesen, Am J Infect Control, vol. 38, no. 6, pp. 430–433, 2010. C
(11) J. L. Holroyd, D. A. Paulus et al., Anesth Analg, vol. 118, no. 2, pp. 333–343, 2010. D
(12) H. Hong, D. F. Morrow, T. J. Sandora, and G. P. Priebe, Am J Infect Control, vol. 41, no. 8, pp. e77–e79, 2013. D
(13) W. Kaler and R. Chinn, JAVA, vol. 12, no. 3, pp. 140–147, 2007. D
(14) J. P. Kennedy, R. A. Lasher, D. Solomon, and R. W. Hitchcock, J Medical Devices, vol. 4, no. 2, Article ID
027509, 2010. D
(15) C. Leon, F. Alvarez-Lerma, S. Ruiz-Santana et al., Crit Care Med, vol. 31, no. 5, pp. 1318–1324, 2003. D
(16) M. Leone and L. Dillon, J Infusion Nsg, vol. 31, no. 2, pp. 84–91, 2008. C
(17) M. Leone and M. Pratt, Infusion, pp. 10–13, Nov/Dec 2011. D
(18) J. L. Lockman, E. S. Heitmiller, J. A. Ascenzi, and I. Berkowitz, Anesth, vol. 114, p. 958, 2011. D
(19) R. W. Loftus et al., Anesthesia, vol. 115, no. 5, pp. 1109–1118, 2012. D
(20) J. Luna, G. Masdeu et al., Eur J Clin Micro Infect Dis, vol. 19, pp. 655–662, 2000. C-D
(21) J. Macias et al., Am J Infect Control, vol. 31, pp. 634–637, 2013. D
(22) D. G. Maki, Clinical Infectious Diseases, vol. 50, no. 12, pp. 1580–1587, 2010. D
(23) M. Mazher et al., Letters in Applied Microbiology, vol. 57, no. 4, pp. 282–287, 2013. D
(24) S. Z. Menyhay and D. G. Maki, Infect Control Hosp Epidemiol, vol. 27, no. 1, pp. 23–27, 2006. D
(25) S. Z. Menyhay and D. G. Maki, Am J Infect Control, vol. 36, no. 10, pp. S174.e171–S174.e175, 2008. D
(26) K. C. Merrill et al., Am J Infect Control, vol. 42, no. 12, pp. 1274–1277, 2014. B-C
(27) M. K. Muffly et al., Am J Infect Control, vol. 38, no. 9, pp. 734–739, 2010. D
(28) J. Oto, H. Imanaka, M. Konno, E. Nakataki, and M. Nishimura, Am J Infect Control, vol. 39, no. 4, pp. 309–313,
2011. B-C
(29) E. Perez et al., Journal of Clinical Microbiology, vol. 52, no. 3, pp. 823–831, 2014. B-C
(30) C. Ramirez, A. Lee, and K. Welch, JAVA, vol. 17, no. 4, pp. 210–213, 2014. B-C
(31) M. E. Rupp, S. Yu, T. Huerta et al., Infect Control Hosp Epidemiol, vol. 33, no. 7, pp. 661–665, 2012. C
(32) K. L. Ruschman and J. S. Fulton, J Intraven Nurs, vol. 16, no. 5, pp. 304–308, 1993. D
(33) C. Salgado et al., Infect Control Hosp Epidemiol, vol. 28, no. 6, pp. 684–688, 2007. C
(34) M. Salzman, H. Isenberg, and L. Rubin, J Clin Microbiol, vol. 31, no. 3, pp. 475–479, 1993. D
(35) S. Sannoh et al., Am J Infect Control, vol. 38, no. 6, pp. 424–429, 2010. C
(36) M. Segura, F. Alvarez-Lerma, J. M. Tellado et al., Ann Surg, vol. 223, no. 4, pp. 363–369, 1996. D
(37) S. Simmons, C. Bryson, and S. Porter, Critical Care Nursing Quarterly, vol. 34, no. 1, pp. 31–35, 2011. D
(38) J. Smith, G. Irwin, M. Viney et al., J Assoc Vasc Access, vol. 17, no. 3, 2012. D
(39) J. S. Soothill, K. Bravery, A. Ho, S. Macqueen, J. Collins, and P. Lock, Am J Infect Control, vol. 37, no. 8, pp.
626–630, 2009. C
(40) C. Stango, D. Runyon, J. Stern, I. Macri, and M. Vacca, JIN, vol. 37, no. 6, pp. 1–4, 2014. C
(41) M. A. Sweet, A. Cumpston, F. Briggs, M. Craig, and M. Hamadani, Am J Infect Control, vol. 40, no. 10, pp.
931–934, 2012. C-B
(42) M. Wright, J. Tropp, D. Schora et al., Am J Infect Control, vol. 41, no. 1, pp. 33–38, 2012. C-B
(43) J. C. Yebenes, M. Delgado, G. Sauca et al., Crit Care Med, vol. 36, no. 9, pp. 2558–2561, 2008. D
∗Grade of recommendation was modified from the NHMRC definitions (NHMRC, 2009) [102]. To achieve a grade of A the research is required to be a high
quality randomized control trial (RCT) or a systematic review of high quality RCTs. Laboratory (in vitro) research was classified as level V evidence (DeVries
and Berlet, 2010 [103]; The University of Newcastle Australia, 2014 [104]).
A: body of evidence can be trusted to guide practice, systematic review or RCT.
B: body of evidence can be trusted to guide practice in most situations, RCT or high quality observational study.
C: body of evidence provides some support for recommendation but care should be taken in its application, observational studies.
D: Level V evidence or evidence that is weak and recommendation must be applied with caution, expert opinion, animal or laboratory studies.
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Table 2: Needleless connector literature.
Grade∗
(1) E. Bouza et al., J Hosp Infect, vol.54, no. 4, pp. 279–287, 2003. B
(2) B. Caillouet, J Assoc Vasc Access, vol.17, no. 2, pp. 86–89, 2012. C
(3) D. Cain and G. Jones, “Comparison of catheter occlusions between a mechanical valve injection cap and
positive displacement injection cap,” Poster NHIA, Dallas, Tex, USA, April 12–15, 2010. C
(4) A. L. Casey, S. Burnell et al., J Hosp Infect, vol. 65, no. 3, pp. 212–218, 2007. B-C
(5) A. L. Casey, T. Worthington, P. A. Lambert, D. Quinn, M. H. Faroqui, and T. S. Elliott, J Hosp Infect, vol. 54, no.
4, pp. 288–293, 2003. B-C
(6) C. Chernecky and J. Waller, J Adv Nsg, vol. 67, no. 7, pp. 1601–1613, 2011. D
(7) C. C. Chernecky, D. Macklin, W. R. Jarvis, and T. V. Joshua, AJIC, vol. 42, no. 2, pp. 200–202, 2014. B-C
(8) S. Cicalini, F. Palmieri, and N. Petrosillo, Critcal Care, vol. 8, pp. 157–162, 2004. B-C
(9) J. M. Costello, D. F. Morrow et al., Pediatrics, vol. 121, pp. 915–923, 2008. C
(10) ECRI Institute, “Evaluation: needleless connectors,” Health Devices, vol. 37, no. 9, pp. 261–281, 2008. D
(11) C. E. Edmiston, V. Markina, AJIC, vol. 38, pp. 421–423, 2010. D
(12) F. Esteve, M. Pujol, E. Limon et al., Journal of Hospital Infection, vol. 67, no. 1, pp. 30–34, 2007. B-C
(13) Hadaway L., J Assoc Vasc Access, vol. 16, no. 1, pp. 20–33, 2011. D
(14) M. Ishizuka, H. Nagata, K. Takagi, and K. Kubota, Int Surg, vol. 98, pp. 88–93, 2013. C
(15) W. Jarvis, C. Murphy, K. Hall et al., Clin Infect Dis, vol. 49, no. 12, pp. 1821–1827, 2009. C
(16) N. Khalidi, D. S. Sovacevich, L. F. Papke-O’Donnell, and I. Btaiche, J Assoc Vasc Access, vol 14, no. 2, pp. 84–91,
2009. C
(17) B. S. Niël-Weise, T. J. Daha, P. J. van den Broek, J Hosp Infect, vol. 62, no. 4, pp. 406–13, 2006. A
(18) C. Salgado, L. Chinnes, T. Paczesny, and J. Cantey, Infect Control Hosp Epidemiol, vol. 28, no. 6, pp. 684–688,
2007. C
(19) S. Schilling, D. Doellman, N. Hutchinson, and B. R. Jacobs, J Paren Ent Nut, vol. 30, no. 2, pp. 85–90, 2006. B-C
(20) R. J. Sherertz, T. B. Karchmer, E. Palavecino, and W. Bischoff, European J Clin Micro Infect Dis, vol. 30, no. 12,
pp. 1571–1577, 2011. C
(21) L. Steininger, “In search of zero: eight years of interventions lead to reduced central line associated
bloodstream infection rates,” Poster 5th Decennial International Conference on Healthcare-Associated Infections,
Organized by SHEA, CDC, APIC, and IDSA, Atlanta, Ga, USA, March 2010.
C
(22) Y. P. Tabak, W. R. Jarvis, X. Sun, C. T. Crosby, and R. S. Johannes, Am J Infect Control, vol. 42, no. 12, pp.
1278–1284, 2014. A
(23) J. C. Yébenes, R. Mart́ınez, M. Serra-Prat et al., Am J Infect Control, vol. 31, no. 8, pp. 462–464, 2003. D
(24) J. C. Yébenes, L. Vidaur, M. Serra-Prat, J. M. Sirvent, J. Batlle, M. Motje, A. Bonet, and M. Palomar, Am J Infect
Control, vol. 32, no. 5, pp. 291–295, 2004. B
∗Grade of recommendation was modified from the NHMRC definitions (NHMRC, 2009) [102]. To achieve a grade of A the research is required to be a high
quality randomized control trial (RCT) or a systematic review of high quality RCTs. Laboratory (in vitro) research was classified as level V evidence (DeVries
and Berlet 2010 [103]; The University of Newcastle Australia, 2014 [104]).
A: body of evidence can be trusted to guide practice, systematic review or RCT.
B: body of evidence can be trusted to guide practice in most situations, RCT or high quality observational study.
C: body of evidence provides some support for recommendation but care should be taken in its application, observational studies.
D: Level V evidence or evidence that is weak and recommendation must be applied with caution, expert opinion, animal, or laboratory studies.
See Figure 1.
must be weighed with consideration for potential negative
factors of design features, poor aseptic practices, and lack of
disinfection that all contribute to risk of infection [2, 121, 122].
Any puncture through the protective skin barrier creates
a portal for bacteria to enter the body. Recognized routes of
catheter contamination are classified as either extraluminal
or intraluminal and include (a) migration of microorganisms
from the skin at the insertion site (considered the source
in short term infections), (b) catheter hub contamination,
(c) hematogenous seeding from another infection source in
the body, and (d) direct contamination from an infusate
[8, 108, 123]. After insertion of a catheter, introduction
of microorganisms occurs primarily from two routes: the
skin/insertion track or through the lumen of the catheter [15,
124–127]. The greatest risk for contamination of the catheter
after insertion is the access hub with 33–45% (402/900)
contaminated in normal patient use [6, 15, 128–132]. In
early studies by Sitges-Serra colonization of the catheter
hub was considered the primary pathogenesis of catheter
associated infection [15, 113]. Linares and colleagues reported
14 episodes of sepsis (70% of total catheter related septic
events) resulted from hub-related contamination [127, 133].
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Table 4: Why disinfect? Sources of contamination literature.
Year
(1) B. Brismar, L. Jordahl et al., Clinical Nutrition, vol. 6, no. 1, pp. 31–33, 1984. 1984
(2) I. F. Btaiche, D. S. Kovacevich et al., Am J Infect Control, vol. 39, no. 4, pp. 277–283, 2011. 2011
(3) A. R. Burrell, M. L. McLaws et al.,Med J Aust, vol. 194, no. 11, pp. 583–587, 2011. 2011
(4) C. Chernecky, “Biofilm formation in connectors characterized by using electron microscopy,” Abstract Assoc Vasc Access
Scientific Conference, National Harbor, M.d., USA, September 2014. 2014
(5) D. Cozanitis and P. Makela, Acta anaesthesiologica Belgica, vol. 59, no. 2, pp. 59–63, 2008. 2008
(6) J. Davis, “Pennsylvania patient safety authority 2011,” Patient Safety Advisory, vol. 8, no. 3, pp. 100–104, 2011. 2011
(7) R. Donlan, Curr Top Microbiol Immunol, vol. 322, pp. 133–161, 2008. 2008
(8) R. M. Donlan and J. W. Costerton, Clinical Microbiology Reviews, vol. 15, no. 2, pp. 167–193, 2002. 2002
(9) R. Donlan, Emerging Infection Diseases, vol. 7, no. 2, pp. 277–281, 2001. 2001
(10) L. Hadaway, Nursing Management, vol. 39, no. 10, p. 17, 2008. 2008
(11) L. Hadaway, J Infus Nurs, vol. 35, no. 4, pp. 230–240, 2012. 2012
(12) L. Hadaway, Journal of Infusion Nursing, vol. 26, no. 1, pp. 44–48, 2003. 2003
(13) J. Liñares, A. Sitges-Serra, J. Garau, J. Perez, and R. Martin, Journal of Clinical Microbiology, vol. 21, no. 3, pp. 357–360,
1985. 1985
(14) B. L. Lobo, G. Vaidean et al., J Hosp Med, vol. 4, no. 7, pp. 417–422, 2009. 2009
(15) J.-C. Lucet, J. Hayon et al., Infection Control and Hospital Epidemiology, vol. 21, no. 1, pp. 40–42, 2000. 2000
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important role with infection risk the longer the catheter
is in place [15]. Intraluminal contamination and subsequent
colonization become more prominent with longer dwell
times [110, 147]. Perez and associates found 59% (42/75) of one
group of NC colonized with biofilm and Salzman found that
71% (20/28) of catheter related infections originated in the
catheter hub presumably from contamination [15, 21, 22, 148].
Clearly hub contamination is a causative element in catheter
related infections and one that demonstrates the necessity for
effective hub disinfection prior to access [110, 113, 127, 133, 144,
149].
3.2. What to Disinfect? Disinfection points to gain access to
intravenous or intravascular devices may include tubing side
ports, direct catheter connections, stopcocks with needle free
caps, NC of various types (split septum, mechanical valves,
positive pressure valves, zero, or neutral connectors), tradi-
tional silicone septum, or other forms of access integrated
with the catheter or tubing. Any intravascular access point
with a surface open to the environment requires disinfection
prior to use, as it acts as the immediate portal of entry for
intraluminal contaminants [23, 99, 113, 127, 133, 144, 150–
152]. Needle free devices constitute more than 80% of access
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Table 6
Recommendations for disinfecting practices Levels ofevidence∗
1
Use disinfection on surfaces of needleless connectors, stopcocks and other intravascular
access ports immediately prior to any connection, infusion or aspiration with appropriate
antiseptic agent (e.g., alcoholic chlorhexidine, povidone iodine, an iodophor, or 70%
alcohol). Access catheter connections with sterile devices only [8–11].
B
2
Antimicrobial caps/port protectors may be effectively used for passive continuous hub
disinfection on needleless connections in accordance with manufacturer instructions, in
conjunction with frictional antiseptic wiping between applications and access
[2, 6, 10, 12–51].
B-C
3 Ensure compliance with hand hygiene, gloving and aseptic practices prior to any contactwith intravenous devices and add-on equipment [6, 8, 10, 30, 52–59]. B
4 Establish and educate all clinical staff on a standard protocol to disinfect catheter hubs,needleless connectors and ports prior to and after each access [11, 20, 60–63]. B-C
5 Provide consistent and varied staff education on consequences of poor technique along withclinical reminders of best practice [10, 13, 51, 54, 60, 64–87]. C
6 Establish regular surveillance of compliance for disinfection of intravascular devices prior toaccess with reporting of results to each care unit [1, 67, 72, 78, 88–96]. C
7 Establish a formal process to evaluate new technology and needleless connector designs[7, 71, 97, 98]. A
8 Implement a multimodal quality improvement infection prevention program that appliesguidelines and recommendations to all intravascular practices [68, 78, 85, 99–101]. B
∗Grade of recommendation was modified from the NHMRC definitions (NHMRC, 2009) [102]. To achieve a grade of A the research is required to be a
high quality randomized control trial (RCT) or a systematic review of high quality RCTs. Laboratory (in vitro) research was classified as level V evidence
(DeVries and Berlet, 2010 [103]; The University of Newcastle Australia, 2014 [104]).
A: body of evidence can be trusted to guide practice, systematic review or RCT.
B: body of evidence can be trusted to guide practice in most situations, RCT or high quality observational study.
C: body of evidence provides some support for recommendation but care should be taken in its application, observational studies.
D: Level V evidence or evidence that is weak and recommendation must be applied with caution, expert opinion, animal, or laboratory studies.
devices, are recommended by Centers for Disease Control for
all tubing/catheter access, and are now more common than
traditional covered septal access ports which allowed needles
to pass easily through the silicone or rubber covered access
[8, 153]. Primary areas of focus for disinfection of access sites
are the point where the sterile syringe or tubing contacts the
site, as in the top septum surface, and the threads or side
surfaces [7, 143, 154]. Manufacturers are required to include
instructions for device use and disinfection recommenda-
tions with each product to guide in the correct and safe usage
of the NC.
Effective disinfection of a NC is influenced by several
factors including: ability to clean the NC surface, the amount
and position of grooves or gaps present, and the roughness
or smoothness of the septum [1, 3, 7, 69, 150, 154–156]. All
NC consist of a septum, a fluid pathway and a mechanism
for activation; the design, space, volume, and human factors
all affect how easy a product is to use and disinfect, and
may also act as contributors to the potential risk of catheter
associated bloodstream infection [3, 69, 150, 155, 157, 158]. NC
have gaps of differing widths between the septal seal and the
housing which may allow ingress of microorganisms [7, 23,
99, 143]. Adequate cleaning or need for additional cleaning
of the septal access site may be based on the specific design
features of the individual NC [2, 4, 5, 7, 70, 111, 129, 153, 159–
161]. New products or technology should be transitioned into
a healthcare facility only after a complete evaluation of both
the research and the performance of the product to determine
the impact of the change on patient outcomes [71, 97, 98, 149,
160, 162–166].
3.3. Disinfection Practices. Recommendations from both the
Centers for Disease Control and the Infusion Nurses Society
state clinician should minimize contamination risk by disin-
fection the access ports of the add-on device using friction
with an appropriate disinfectant (70% alcohol, chlorhexidine,
povidone iodine, and iodophors) prior to any access [8,
11, 24, 167, 168]. The 70% isopropyl alcohol wipe is most
commonly used to disinfect the access surface of NC and
has been proven effective or ineffective at disinfection times
from 5 seconds to 60 seconds [14, 19, 24–27, 131, 151, 169–
177]. The major biocide effect of alcohol occurs while wet
and immediately after drying, allowing for dehydration
of bacterial cells, whereas alcoholic chlorhexidine is most
effective during the drying process, where it enters the
cell to cause destruction providing ongoing antimicrobial
effect [150, 172]. The disinfecting action of chlorhexidine in
combination with alcohol, allowing for both immediate and
sustained action; has proven to be more effective than either
agent alone [21, 131, 168, 172, 176, 178–180]. Faster drying
time with alcohol makes it superior to other disinfection
agents and provides an advantage to chlorhexidinewhen used
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in combination. Effectiveness of 70% alcohol disinfection
is variable based on application techniques and character-
istics of NC surface and design, leading some researchers
to conclude that complete disinfection of microorganisms
on some NC surfaces may not be achievable [12]. In the
Menyhay prospective in vitro study, 20 (67%) of 30 NC
disinfected with 70% alcohol resulted in transmission of
contaminants (442–25,000CFU) yet 60 tested with barrier
caps (containing 2% chlorhexidine and 70% alcohol) showed
only one (1.6%) with transmission of contaminants [19]. In
both the Kaler laboratory and the Ruschman randomized
experimental design studies, using a 15 second and 60 second
scrub respectively, disinfection with 70% alcohol eliminated
all microorganisms [173, 181]. Kaler performed laboratory
testing on contaminated NC with a small sample using 70%
alcohol and alcoholic chlorhexidine and found both to be
effective for hub disinfection [181]. Two additional studies
gave conflicting results. Rupp demonstrated 5 second alcohol
disinfection was effective; this was in direct contrast with
the Smith study where contact time of 10/12/15 seconds was
deemed adequate, but 5 and 8 seconds were not as effective to
prevent bacterial transfer [170, 171]. Simmons and colleagues
found 3/10/15 seconds significantly decreased the bacterial
load in an in vitro laboratory study,with some level of bacteria
remaining during all duration levels tested; disinfection failed
to completely eliminate contaminants [13]. More studies are
needed to provide efficacy for optimal time necessary to
eliminate surface contaminants.
Research of Macias and associates with 2% chlorhexidine
in 70% isopropyl alcohol on skin proved an added substantive
effect, even against freshly introduced organisms, for up to
24 hours, establishing this agent as a superior disinfecting
agent when longer action is needed, in comparison with
single agents of 70% isopropyl alcohol, 10% povidone iodine
and 10% sodium hypochlorite [172]. Alcoholic chlorhexidine
performed consistently well or better than other disinfection
agents in multiple studies [21, 24, 131, 168, 172, 179, 182].
In the research by Hong et al., a 5 second scrub with
alcoholic chlorhexidine fully disinfected NC surfaces treated
with Pseudomonas Aeruginosa [179]. In the most recent
Epic3 United Kingdom report of evidence-based guidelines,
recommendations by expert consensus include a 15 second
cleansing with alcoholic chlorhexidine prior to and after each
access [53]. In actual practice disinfection prior to access is
expected, while cleansing after each access is rarely done.
3.4. Passive Disinfection. Disinfection research includes var-
ious forms of passive antimicrobial hub protection with
70% alcohol caps (SwabCap, Excelsior Medical, Neptune,
NJ; Curos Port Protector, Ivera Medical, San Diego, CA;,
EffectIV-Cap, Hospira, Lake Forest, IL; DualCap, Catheter
Connections, Salt Lake City, UT), iodinated alcohol hub,
povidone iodine gauze and specialty covers, and combination
chlorhexidine/alcohol caps [12, 14, 18, 19, 23, 25–43, 146,
178, 183–192]. In a randomized prospective trial by Pittiruti,
46 catheters received a 70% alcohol port protector with no
detected CLABSIs over 707 catheter days, colonization in
two catheters and no contaminated blood cultures [18]. Of
note the Pittiruti study resulted in reductions of CLABSIs
in the port protector/disinfection cap group and the control
group, with improvements attributed to both the disinfection
caps and educational efforts. These disinfection caps applied
and left in place provide active mechanical friction along
with longer contact time creating a physical and chemical
barrier between the lumen and the environment [26]. As a
progressive CLABSI intervention Posa at St. Joseph Mercy
Health System implemented an insertion bundle, chlorhex-
idine bathing, a maintenance bundle, chlorhexidine dressing
for central catheters, and educational programs, however it
was not until implementing the 70% alcohol disinfection cap
that their rates of CLABSI fell to zero and remained from 2011
to the end of 2012 The disinfection cap placed on all access
ports eliminates human factor issues requiring clinicians to
remember to carry the necessary disinfection supplies to
the bedside or even to remember to perform the act of
disinfection before each access [187]. An in vivo hospital
study by DeVries gave nurses a choice to use either this single
use cleansing cap or a disinfection cap to leave on the NC
access site, clinicians preferred the longer lasting disinfection
cap [14]. In another retrospective study, Schears noted a pre-
disinfection cap CLABSI rate of 1.682/1000 catheter days and
a CLABSI rate of 0.6461/1000 catheter days after implement-
ing disinfection caps, representing a statistically significant
61% reduction in CLABSI [32]. In Wright et al.’s study at
NorthShore University HealthSystem, a four University Hos-
pital system, the intervention with 70% alcohol disinfection
caps reportedCLABSI rates declining from 1.42/1000 catheter
days (16/11,540) to 0.69 (13/18,972) with a 95% confidence
interval, based on 799 enrolled patients, representing a
statistically significant decrease [26]. Another alcoholic hub
protector study by Sweet et al. included 472 patients and
3005 catheter days and showed a decrease in overall CLABSIs
from 2.3 to 0.3/1000 catheter days and a PICC CLABSI
reduction from 2.3 to 0, a statistically significant change, with
an 85.2% compliance rate [31]. Stango and associates reported
a 50% reduction in CLABSIs and a savings of $464,440 per
year after alcoholic cap implementation [184]. Numerous
studies have demonstrated consistent clinical effectiveness
of 70% alcohol caps alone in studies and abstracts graded
C or D [18, 26, 27, 31, 33, 41, 43, 178, 189, 191–194]. Alcoholic
chlorhexidine caps are also effective in preventing con-
tamination and completely disinfecting NC access surfaces
(combination of alcoholic chlorhexidine in cap form is not
commercially available in the USA) [2, 12, 19, 178, 179].
Another engineered solution for hub cleaning involves
a 70% alcohol foam cap (Site Scrub, Bard Access, Salt Lake
City, UT) designed for use as an access site cleansing cap
for single use, then discarded. The Holroyd in vitro study at
University of Florida compared the single use of this cleansing
cap with 70% alcohol to traditional 70% alcohol wipes [151].
When the cleansing cap was used on stopcocks Holroyd
found contamination and increased CFU. This study found
70% alcohol wipes and this alcohol cleansing cap were both
effective on the surface of NC and catheter hubs [151]. Other
groups also used this single use cleansing cap in combination
with other 70% alcohol disinfecting caps designed to be left
in place until the next access [14, 177].
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3.5. Clinical Implications. Since the advent of NC as access
hubs for the administration of medications or fluids, there
has been a need to verify compliance with disinfection
practices prior to access. During the period of needle usage
for catheter access, nurses and doctors intuitively knew the
necessity of disinfecting the access septum prior to inserting
a needle. With NC, these questions arise: is disinfection
always performed prior to access? Is disinfection performed
in an effective manner? Do clinicians fully understand the
consequences of not performing disinfection? Disinfection
practices with alcohol or alcoholic chlorhexidine that include
adequate contact disinfection time are effective if performed
at all. According to a recent publication by Ryder, an issue
was raised regardingwhether failure to disinfect is considered
a medical error and if so, is this omission considered negli-
gence? [100] Catheter associated infections are a significant
safety issue, and contamination caused by lack of aseptic
technique is preventable. Once contamination occurs, bacte-
ria attach to the inner lumen of the catheter, begin to grow
and form biofilm, making successful eradication extremely
difficult [6, 28–30, 113, 127, 133, 140–142, 144, 195]. Joint
Commission now requires hospitals in the USA to protect
patients by having a standard and measurable protocol for
hub/access site disinfection [61, 62, 196]. Measurement of
compliance with hub disinfection is challenging, requiring
direct observation of the action unless disinfection caps/ports
are used on all NC hubs as a form of verification. Passive
disinfection through hub protectors/disinfection caps have
differing designs and colors, leading to easy recognition
and validation of compliance with usage. Reimbursement
structures in the USA that now promote pay for performance
and penalize poor outcomes will assist in driving these
passive safety strategies that aid inmonitoring and improving
compliance with disinfection.
3.6. Issues of Compliance and Monitoring. While policies for
disinfection of access devices are a first step, methods to
validate actual practice and patient safety must be integrated
into hospital culture.The central line bundle checklist is used
as evidence to demonstrate compliance with safety practices
during insertion, but the aspect of day to day management
is not addressed in the bundle. Care and management of
catheters takes up more than 99% of the dwell time of
a catheter compared to the one hour or less for catheter
insertion. Compliance with aseptic practice is important for
both insertion and daily usage. Consistent hand hygiene and
gloving performed prior to any procedure or even touching of
a catheter helps reduce bacterial transfer. Application of alco-
holic chlorhexidine to disinfect skin for central line insertions
and now, more and more with peripheral catheter insertions,
is helping to reduce bacterial ingress to the bloodstream.
Maximum sterile barriers also reduce contamination during
the insertion process so that overall, CLABSI rates occurring
in the first few days of insertion continue to fall.
Even with the success of the Central Line Bundle on
CLABSI reductions, a majority of hospitals remain well
above zero for infections. Access and maintenance activities
with the catheters may be to blame. When CLABSIs occur
well after the 96 hour mark, contamination of the catheter
through the NC is likely the culprit. From the evidence
presented, NC and catheter hubs are a primary source of
bacterial contamination, and subsequent transmission of
contamination into the catheter lumen [6, 30, 113, 127, 133, 142,
144]. Just one omission of scrubbing the hub prior to access
permits bacterial entry, attachment and biofilm formation
that allow the bacteria to strengthen prior to release into
the bloodstream. Preventing this form of contamination
requires teaching and constant reinforcement of the required
practice of regular and consistent disinfection prior to every
access. Verification of compliance with hub disinfection by
clinicians requires direct observation of the action unless
disinfection hub protectors are used, providing a form of
passive immediate visual verification. More andmore studies
are demonstrating lack of compliance with hub disinfection
despite educational initiatives and better disinfection agents.
Disinfection methods that incorporate prolonged duration
of contact with an antiseptic agent to significantly decrease
the level of surface bacteria present may provide a solution
to the problem of hub contamination and variation in NC
designs.
Various studies provide statements regarding conformity
or lack of conformity concerning disinfection practices,
attributing noncompliance to a lack of universal protocols,
excessive workloads (e.g., when clinicians become busy, they
are less likely to comply), or just forgetting to bring alcohol
wipes to the bedside [54, 64, 72, 89–93, 188]. The Smith
study on behavioral intention indicated a negative correlation
between performing optimal disinfection with increasing
age of clinicians and more years of experience [91]. Clearly
there are human factors working against disinfection of hubs
prior to access requiring engineered solutions such as passive
disinfecting cap strips hanging on intravenous pump poles,
supply dispensers of alcohol wipes at the bedside, or on the
intravenous pump to ensure greater, even 100% compliance
with disinfection each and every time [91, 170]. Monitoring
and validation of hub disinfection compliance is necessary to
determine if other measures are needed such as disinfection
caps/port protectors. In an evaluation of 5877 physicians,
nurses and technicians, Jardim et al. documented compliance
with hub disinfection 38.7% of the time, leaving more than
61% of accesses without disinfection, leading to possible con-
tamination and biofilm growth [92]. Platace et al. evaluated
clinician hands during invasive procedures demonstrating
100% of the 48 nurses sampled exceeded acceptable levels
of microorganisms, with the potential to contaminate and
cause bloodstream infection [90]. Studies show there is a
need for clear recommendations and practices that prevent
transmission of contaminants throughNC [68, 90]. Targeting
of education for providers responsible for CVAD insertion
and care for identifying appropriate indications, performing
insertion with the central line bundle, performing surveil-
lance of CLABSI and scrubbing the hub with an appropriate
antiseptic are Category IA recommendations by AHRQ as
critical components of a comprehensive CLABSI prevention
program [9].
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3.7. Risk of Bias and Limitations. This systematic review
highlights the lack of available high quality research in this
area that tests the cause and effect relationship between
NC disinfection practices and patient infection outcomes.
It also asks the question “What are we basing our clinical
practice guidelines on for disinfection of NC?” Absence
of high quality RCT evidence required authors to include
any clinical observational and cohort studies and laboratory
studies. Overall, the evidence base for the effectiveness
of various disinfection strategies is low level, resulting in
recommendations compiled from the available publications.
The strength of this review is that it includes all relevant,
currently available pieces of evidence; however there remains
a high level of uncertainty in the estimates of effectiveness
of various decontamination techniques, and these are highly
likely to change with the publication of new studies in the
literature. Studies to date have a risk of unintentional bias due
to the lack of randomization and control groups/strategies,
in addition to small sample sizes and retrospective study
designs. Randomized controlled studies are needed to rig-
orously evaluate the efficacy of disinfection practices and
antiseptic hub protectors in preventing patient infection.
3.8. Research Priorities. Adequately large randomized con-
trolled trials are urgently needed to establish high quality
evidence of the efficacy of various disinfection practices to
prevent infection. Randomized controlled trials are needed to
identify if risk reduction differs with the type of antiseptic, for
example, 70% alcohol versus 70% alcohol and chlorhexidine,
or with differing concentrations of chlorhexidine in their
efficacy for disinfection NC. Research may also validate the
substantive effect of alcoholic chlorhexidine on NC and its
continued antimicrobial activity on these surfaces, poten-
tially establishing a reduced cleaning frequency or duration
for NC. Study considerations for passive disinfection cou-
pled with prefilled flush syringes could demonstrate drastic
reduction of hub contamination and intraluminal biofilm
colonization, but ultimately patient infection outcomes are
needed. Research that replicates solid studies provides a
stronger foundation for evidence-based practice and should
be encouraged. Translational research is growing, providing
clinical implications that directly apply to bedside practices
[14, 57–59, 67, 70, 73–75]. NC disinfection is an excellent
subject for efficacy studies utilizing comparative research for
various disinfection approaches identifying relative reduc-
tions in patient infection risk. Claire Rickard, Ph.D., Professor
of Nursing with Griffith University, states it well “We are
belatedly realising that to eliminate these complications
(infections) we must conduct research, implement evidence-
based interventions and reduce the clinical practice variations
that lead to their occurrence” [197]. Research and study
are necessary as an integral part of professional practice,
providing a means to direct clinical activity and to share with
rising young clinicians long after we are gone.
4. Conclusion
Aseptic technique is the foundation for safe delivery of
intravenous medications and solutions. More and more
studies reveal lack of compliance with disinfection of access
ports prior to and after access, despite educational initiatives,
and better disinfection agents [1, 26, 27, 38, 54, 57, 64,
67, 69, 72, 74, 78, 83, 88–93, 188, 198–205]. Rather than
creating devices such as the ultraviolet C port to eradicate
contaminationwithin the hub, the goal should be to eliminate
surface pathogens before entering the NC or catheter. Passive
disinfection caps reduce guess work, provide clinicians with a
point of use solution, and reduce contamination. It is critical
for healthcare facilities and clinicians to take responsibility
for compliance with aseptic technique for NC disinfection,
to monitor compliance regularly, to involve frontline staff in
solutions, and to facilitate education that promotes under-
standing of the consequences of failure to comply with the
standard of care for access site disinfection.
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[70] J. C. Yébenes, M. Delgado, G. Sauca et al., “Efficacy of three
different valve systems of needle-free closed connectors in
avoiding access of microorganisms to endovascular catheters
after incorrect handling,” Critical Care Medicine, vol. 36, no. 9,
pp. 2558–2561, 2008.
[71] J. Segreti, S. Garcia-Houchins, L. Gorski et al., “Consensus con-
ference on prevention of central line-associated bloodstream
infections: 2009,” Journal of Infusion Nursing, vol. 34, no. 2, pp.
126–133, 2011.
[72] W. Zingg, A. Imhof, M. Maggiorini, R. Stocker, E. Keller,
and C. Ruef, “Impact of a prevention strategy targeting hand
hygiene and catheter care on the incidence of catheter-related
bloodstream infections,” Critical Care Medicine, vol. 37, no. 7,
pp. 2167–2173, 2009.
[73] D.K.Warren, J. E. Zack,M. J. Cox,M.M.Cohen, andV. J. Fraser,
“An educational intervention to prevent catheter-associated
bloodstream infections in a nonteaching, community medical
center,”Critical CareMedicine, vol. 31, no. 7, pp. 1959–1963, 2003.
[74] C.M. Coopersmith, J. E. Zack, M. R.Ward et al., “The impact of
bedside behavior on catheter-related bacteremia in the intensive
care unit,” Archives of Surgery, vol. 139, no. 2, pp. 131–136, 2004.
[75] A. Corona and F. Raimondi, “Prevention of nosocomial infec-
tion in the ICU setting,”Minerva Anestesiologica, vol. 70, no. 5,
pp. 329–337, 2004.
[76] K. Cooper, G. Frampton, P. Harris et al., “Are educational inter-
ventions to prevent catheter-related bloodstream infections in
intensive care unit cost-effective?” Journal of Hospital Infection,
vol. 86, no. 1, pp. 47–52, 2014.
[77] G. K. Frampton, P. Harris, K. Cooper et al., “Educational
interventions for preventing vascular catheter bloodstream
infections in critical care: evidence map, systematic review and
economic evaluation,”Health Technology Assessment, vol. 18, no.
15, pp. 1–365, 2014.
[78] A. S. McAlearney and J. L. Hefner, “Facilitating central line–
associated bloodstream infection prevention: a qualitative study
comparing perspectives of infection control professionals and
frontline staff,” American Journal of Infection Control, vol. 42,
no. 10, supplement, pp. S216–S222, 2014.
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